本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Coherent

293.12
+3.191.10%
成交量:514.13萬
成交額:15.33億
市值:573.46億
市盈率:71.15
高:312.42
開:302.91
低:290.10
收:289.93
52周最高:440.00
52周最低:100.63
股本:1.96億
流通股本:1.95億
量比:0.82
換手率:2.64%
股息:- -
股息率:- -
每股收益(TTM):4.12
每股收益(LYR):4.12
淨資產收益率:7.98%
總資產收益率:3.39%
市淨率:5.26
市盈率(LYR):71.15

資料載入中...

2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

重要事件披露

8-K - Current report
2021/01/19

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/19

重要事件披露

8-K - Current report
2020/12/21

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/12/21

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/12/21

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/12/21

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/12/21

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/12/21

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/12/21

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/12/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/10

重要事件披露

8-K - Current report
2020/08/20

重要事件披露

8-K - Current report